MYD88 and diffuse large B-cell lymphoma: Mutations in MyD88 (S149G, S149I, S150I) or in the MATH domain of SPOP (F102I, D140H), commonly associated with DLBCL, disrupt the SPOP-MyD88 interaction and inhibit MyD88 ubiquitination 90.